insights_auto
Nega ALC oshdi 4,75%?
Batafsil oʻrganishchevron_right
ALC:NYSE
Alcon AG
70,63Â US$
arrow_upward
+4,75%(+3,20) 1K
70,13Â US$
arrow_downward
-0,71% (-0,50)todayBirjadan oldin
Savdolar yopilgan: 22-okt, 16:00:07 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoALC tikeri uchun statistika yaratilmoqda...
Ochish
68,02Â US$
Yuqori
70,68Â US$
Past
67,96Â US$
Bozor kapitali
28,90Â mlrd
Oʻrtacha hajm
1,75Â mln
Hajmi
1,01Â ming
52 haftalik eng yuqori
87,64Â US$
52 haftalik eng past
61,84Â US$
Beta
0,88
Muomaladagi aksiyalar
483,40Â mln
Xodimlar soni
25Â ming
Ochish
68,02Â US$
Yuqori
70,68Â US$
Past
67,96Â US$
Bozor kapitali
28,90Â mlrd
Oʻrtacha hajm
1,75Â mln
Hajmi
1,01Â ming
52 haftalik eng yuqori
87,64Â US$
52 haftalik eng past
61,84Â US$
Beta
0,88
Muomaladagi aksiyalar
483,40Â mln
Xodimlar soni
25Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
GuruFocus
·
9 soat oldin
Alcon Inc (ALC) Shares Surge 4.8% -- What GF Score of 74 Tells I
Yahoo Finance
·
2 kun oldin
Alcon Acquires Neurotech and ENCELTO, the Only FDA-Approved Treatment for MacTel Type 2
Profil
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
Alcon AG haqida
CEODavid J. Endicott
Xodimlar soni25Â ming
Asos solingan1945
Bosh ofislarJeneva, Geneva, Shveytsariya
Sektor-
Veb-saytalcon.com